Global Canine Arthritis Treatment Market
Veterinary Healthcare

Emerging Growth Drivers in the Canine Arthritis Treatment Market Landscape: Rising Pet Ownership Rates Drive Growth In Canine Arthritis Treatment Market

Discover trends, market shifts, and competitive outlooks for the canine arthritis treatment industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Key Projections for the CAGR of the Canine Arthritis Treatment Market Size From 2025 to 2034?

In recent times, the market size for canine arthritis treatment has consistently seen robust growth. It is projected to expand from $2.35 billion in 2024 to $2.48 billion in 2025, marking a compound annual growth rate (CAGR) of 5.6%. Factors such as the rise in the elderly pet population, heightened knowledge amongst pet owners, focus on preventive healthcare, growth in disposable income, and escalating expenses in veterinary healthcare have contributed significantly to the historical growth of this market.

The market for treating canine arthritis is projected to experience robust expansion in the forthcoming years. A compound annual growth rate (CAGR) of 5.4% is anticipated, which will propel the market to reach $3.06 billion by 2029. Factors contributing to this projected growth within the forecast period include an increase in pet insurance adoption, a surge in arthritis cases, escalating numbers of pet owners, a rising demand for less invasive surgical treatments, and a higher incidence of arthritis within the canine population. The forecast period will also likely see trends such as ground-breaking treatment methods, progress in the field of veterinary medicine, the call for improved therapies, the incorporation of technology, and cutting-edge technologies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16007&type=smp

Which Primay Drivers Are Accelerating Growth in the Canine Arthritis Treatment Market?

The growth of the market for canine arthritis treatment is set to be fuelled by the increasing rates of pet ownership. When we talk about pet ownership, we’re referring to the responsibility and care given by individuals or families to meet the needs, welfare, and companionship of domestic animals that are primarily kept for enjoyment rather than practicality. Changes in lifestyle, the trend to humanize pets, and increases in discretionary income are amongst the factors causing an upsurge in pet ownership rates. To manage and relieve the symptoms of arthritis in their dogs, pet owners turn to canine arthritis treatments, with the objective of enhancing their pets’ quality of life and keeping them mobile. As an example, data from the American Pet Products Association, a not-for-profit organization based in the US, in October 2023 indicated that 86.9 million US households had a pet, representing 66% of all households in 2022. Consequently, the escalating rate of pet ownership is a driving force behind the growth of the canine arthritis treatment market.

Which Primary Segments of the Canine Arthritis Treatment Market Are Driving Growth and Industry Transformations?

The canine arthritis treatment market covered in this report is segmented –

1) By Treatment Type: Drugs, Supplements, Surgical Procedures, Other Treatment Types

2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

3) By Arthritis Type: Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis

4) By Distribution Channels: Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers

2) By Supplements: Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements

3) By Surgical Procedures: Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy

4) By Other Treatment Types: Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=16007&type=smp

Which Regions Are Key Players in the Growth of the Canine Arthritis Treatment Market?

North America was the largest region in the canine arthritis treatment market in 2024. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing the Canine Arthritis Treatment Industry Evolution?

Leading firms in the canine arthritis treatment market are spearheading the creation of new remedies such as bedinvetmab injections to improve joint health and movement in dogs. Bedinvetmab is a type of monoclonal antibody injection which neutralizes the nerve growth factor (NGF), a pain-related protein in veterinary medicine. In May 2023, Zoetis Inc., an American animal health corporation, gained the Food and Drug Administration’s (FDA) approval for Librela, an injectable form of bedinvetmab. This product is a breakthrough as the first FDA-approved monoclonal antibody (mAb) for canine use, functioning by controlling the biological activity of canine nerve growth factor (NGF) which contributes to osteoarthritis (OA) pain. Librela is easily administered by subcutaneous injection on a monthly basis, offering a convenient and prolonged means for managing OA pain in dogs.

View the full report here:

https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report

What Parameters Are Used to Define the Canine Arthritis Treatment Market?

Canine arthritis treatment refers to the medical and therapeutic approaches for canine arthritis disease, a chronic condition characterized by inflammation and progressive deterioration of the cartilage within a dog’s joints. It is used to reduce pain and inflammation, maintain joint function, and slow the progression of the disease in dogs.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16007

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Leave a Reply

Your email address will not be published. Required fields are marked *